✦ LIBER ✦

THE RISKS AND BENEFITS OF ANTIPSYCHOTIC POLYPHARMACY: POTENTIAL FOR NEUROLEPTIC MALIGNANT SYNDROME

✍ Scribed by Robert O. Cotes; Douglas L. Noordsy; Margaret McDermott; Joel N. Peterson; Marcy Traum

Book ID: 119364905
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 75 KB
Volume: 117
Category: Article
ISSN: 0920-9964
DOI: 10.1016/j.schres.2010.02.414

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Neuroleptic malignant syndrome associate

Neuroleptic malignant syndrome associated with the use of risperidone, an atypical antipsychotic agent

✍ Heidi Lee; James Ryan; George Mullett; Brian A. Lawlor 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 248 KB

Neuroleptic malignant syndrome (NMS) is a rare and sometimes fatal adverse reaction to neuroleptic drugs. Atypical antipsychotic agents, such as risperidone, are thought to be less likely to cause N M S because of their phamacologiical profile. This is a case report of NMS associated with risperidon

P.3.051 - Muscle enzymes and white blood

P.3.051 - Muscle enzymes and white blood count as risk factors for the neuroleptic malignant syndrome

✍ H. Hermesh; I. Manor; M. Gianella; H. Munitz; A. Weizman 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 164 KB

Neuroleptic Malignant Syndrome Complicat

Neuroleptic Malignant Syndrome Complicating Antipsychotic Treatment of Delirium or Agitation in Medical and Surgical Patients: Case Reports and A Review of the Literature

✍ Dallas P. Seitz; Sudeep S. Gill 📂 Article 📅 2009 🏛 American Psychiatric Publishing Inc 🌐 English ⚖ 103 KB

Evaluating the Need and Potential Benefi

Evaluating the Need and Potential Benefits of Testing for Plasma Homocyst(e)ine, an Independent Risk Factor for Atherosclerotic Disease

✍ Andrea Irvin-Jones; P. Barton Duell; M.R. Malinow 📂 Article 📅 2000 🏛 Le Jacq Communications, Inc. 🌐 English ⚖ 356 KB

The potential benefits and risks of the

The potential benefits and risks of the use of dual antiplatelet therapy beyond 6 months following sirolimus-eluting stent implantation for low-risk patients

✍ Takafumi Nakagawa; Yoshikazu Hiasa; Shinobu Hosokawa; Tomoko Minami; Yudai Yano; 📂 Article 📅 2011 🏛 Elsevier 🌐 Japanese ⚖ 333 KB

Recommendations for the evaluation of ri

Recommendations for the evaluation of risk and prophylaxis of tumour lysis syndrome (TLS) in adults and children with malignant diseases: an expert TLS panel consensus

✍ Mitchell S. Cairo; Bertrand Coiffier; Alfred Reiter; Anas Younes; on behalf of t 📂 Article 📅 2010 🏛 John Wiley and Sons 🌐 English ⚖ 363 KB